Non-peptide oxytocin agonists
Authors:
- Michael RoeMRMichael Roe
- 1 September 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (17) , 4585-4589
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Characterization of Orally Active Nonpeptide Vasopressin V2 Receptor Agonist. Synthesis and Biological Evaluation of Both the (5R)- and (5S)-Enantioisomers of 2-[1-(2-Chloro-4-pyrrolidin-1-yl-benzoyl)-2,3,4,5-tetrahydro-1H-1-benzazepin- 5-yl]-N-isopropylacetamideJournal of Medicinal Chemistry, 2002
- Identification of potent and selective oxytocin antagonists. Part 1: indole and benzofuran derivativesBioorganic & Medicinal Chemistry Letters, 2002
- WAY-VNA-932Drugs of the Future, 2002
- Structure–activity relationship investigations of a potent and selective benzodiazepine oxytocin antagonistBioorganic & Medicinal Chemistry Letters, 2001
- The Oxytocin Receptor System: Structure, Function, and RegulationPhysiological Reviews, 2001
- Can peptides be mimicked?Drug Discovery Today, 2000
- Nonpeptide oxytocin antagonists: Analogs of L-371,257 with improved potencyBioorganic & Medicinal Chemistry Letters, 1999
- Regioselective Synthesis of Several Heterocyclic Fused Azepines Using Diisobutylaluminum HydrideHETEROCYCLES, 1998
- Separate Agonist and Peptide Antagonist Binding Sites of the Oxytocin Receptor Defined by Their Transfer into the V2 Vasopressin ReceptorJournal of Biological Chemistry, 1996
- Drug delivery studies in Caco-2 monolayers. III. Intestinal transport of various vasopressin analogues in the presence of lysophosphatidylcholineInternational Journal of Pharmaceutics, 1995